Please review our updated Privacy & Cookies Notice.
SEATTLE (April 6, 2015) — The Bill & Melinda Gates Foundation today announced that Emilio Emini, Ph.D, has been named director of HIV for the Global Health program. He will assume his new position on July 6, 2015.
Dr. Emini is currently the Chief Scientific Officer and Senior Vice President of Vaccine Research at Pfizer Inc. He is also a senior advisor to the Gates Foundation’s HIV team. Previously, Dr. Emini served as Senior Vice President and Head of Vaccine Development at the International AIDS Vaccine Initiative. He was also the founding Executive Director of Merck’s Department of Antiviral Research and the Vice President of Merck’s Vaccine and Biologics Research.
“Emilio brings deep experience in HIV and managing complex teams of technical and delivery experts,” said Trevor Mundel, president of Global Health at the Bill & Melinda Gates Foundation. “We have benefited greatly from his role as senior advisor to the HIV team over the past year, and he is an exceptional choice to lead the team going forward.”
Dr. Emini received his doctoral degree in 1980 from the Cornell University Graduate School of Medical Sciences in the fields of microbiology, genetics and biochemistry.
About the Bill & Melinda Gates Foundation
Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people’s health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life. Based in Seattle, Washington, the foundation is led by CEO Sue Desmond-Hellmann and Co-chair William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren Buffett.
Sign up for The Optimist newsletter
Subscribe to The Optimist to get weekly updates on the latest in global health, gender equality, education, and more.